Skip to main content
SpringerLink
Log in

Abacavir/dolutegravir/lamivudine

Various toxicities: 10 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ferrer PE, et al. A retrospective clinical audit of general practices in Australia to determine the motivation for switch to dolutegravir/abacavir/lamivudine and clinical outcomes. International Journal of STD and AIDS 29: 300-305, No. 3, 01 Mar 2018. Available from: URL: http://doi.org/10.1177/0956462417730474 -USA

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abacavir/dolutegravir/lamivudine. Reactions Weekly 1691, 14 (2018). https://doi.org/10.1007/s40278-018-42269-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-42269-0

Search

Navigation